PRZOOM - /newswire/ -
Delhi, New Delhi, India, 2007/07/17 - China’s vaccine market is expected to witness an upturn when it will become a consolidated industry from a fragmented one, thanks to M&As projected for coming three to five years.
The vaccine industry of China, which is largely considered as a fragmented industry, is expected to see big deals being signed and sealed in the coming three to five years, reported a business insider during 2007 International Conference for Bio-economy in Tianjin on June 27, 2007, as published by Interfax China on June 28, 2007.
Currently, there are over 30 vaccine manufacturers in China and as Chen Dagao, General Manager, Jinagsu Yanshen Biological Technology Stock Co. Ltd, has augured, the total count will surpass 40 by 2010 due to the rapid growth of vaccine market in China.
The major forces that will push the vaccine sales high in the country are large investments by government in public immunization programs, foray of more international vaccine manufacturers, and better living standards. Vaccine market in China, presently, is anticipated to be at about RMB 2.8 Billion (over US$ 393.4 Million) and still has the potential to record phenomenal growth in future.
Chinese vaccine market is characterized by small enterprises, with only few products in their portfolio. This comes as an important factor to facilitate a culture of M&As in future. Moreover, now many vaccine makers are expanding their production. This will lead to an oversupply of vaccines in coming 12 months-2 years, said Chen. "An oversupply in the vaccine market will result in mergers and acquisitions," said Chen in a statement reported by Interfax China on June 28, 2007.
“Global Vaccine Market Outlook (2007-2010)”, a recent market report by RNCOS, too positions China as the largest Asian vaccine market. The China National Biotec Corporation is leading the local suppliers, and efforts are being put into place to organize and improve management; private-owned firms are increasing rapidly; international bigwigs have also made inroads into the China’s vaccine market and have started to grab increasingly large shares of high-end vaccines.
The research report presents a prudent analysis of various parameters of the global vaccine market, like past, current and future market trends, major vaccines and their markets, categories of players operating in the vaccine market, and driving forces, challenges and opportunities for the industry. The report also gives a profile discussion of global key players operating in the industry.
About RNCOS E-Services Pvt Ltd
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.